NCT02302885 2026-01-29
Healthy Human Control Blood Collection for Validation of Biomarker Assay
Abramson Cancer Center at Penn Medicine
Completed
Abramson Cancer Center at Penn Medicine
University of Illinois at Chicago
Université Catholique de Louvain
Exact Sciences Corporation
VA Office of Research and Development
Janssen-Cilag International NV
Innovent Biologics (Suzhou) Co. Ltd.
Cancer Care Ontario
Alteogen, Inc.
Institut de Cancérologie de la Loire
AHS Cancer Control Alberta
Lexicon Pharmaceuticals
Institut de Cancérologie de la Loire
St. Jude Children's Research Hospital
Leiden University Medical Center